Home

Katherine Stueland, CEO: GeneDx Holdings WGS Sell · Filed 23/03/13

Trade details

Type
Insider sale
Amount
$33,351.84
Shares · price
92,644 sh · $0.36 a share
Held after
308,574 sh
Trade date
23/03/10
Filed
23/03/13
Days to filing
3 days

Sold 23.1% of holdings

Share of holding sold
23.1%

GeneDx Holdings trades, last 26 weeks

What else happened in GeneDx Holdings around then

Filed or reported within 30 days of the trade day · 23/02/08~23/04/09

Katherine Stueland's recent trades

  • Katherine Stueland

    Planned saleGeneDx Holdings

    $1.2M

    Filed 09/01

  • Katherine Stueland

    SellGeneDx Holdings

    $360.8K

    Filed 06/18

  • Katherine Stueland

    SellGeneDx Holdings

    $149.4K

    Filed 06/18

  • Katherine Stueland

    SellGeneDx Holdings

    $127.9K

    Filed 06/18

  • Katherine Stueland

    SellGeneDx Holdings

    $195.7K

    Filed 06/11

Katherine Stueland, CEO — sold $33.4K of GeneDx Holdings WGS · 23.1% of holdings | Whalegun